The potential impact of Covid-19 on the capacity of routine laboratory tests to detect heparin-induced thrombocytopenia

In Covid-19, anticoagulation with heparin is often administered to prevent or treat thromboembolic events. Heparin-induced thrombocytopenia (HIT) is a severe complication of heparin treatment, caused by heparin-dependent, platelet activating anti-platelet factor 4 (PF4)/heparin antibodies. Diagnosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Draxler, Dominik F., Brodard, Justine, Zante, Björn, Jakob, Stephan M., Wiegand, Jan, Kremer Hovinga, Johanna A., Angelillo-Scherrer, Anne, Rovo, Alicia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510722/
https://www.ncbi.nlm.nih.gov/pubmed/36163073
http://dx.doi.org/10.1186/s12959-022-00411-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510722/
https://www.ncbi.nlm.nih.gov/pubmed/36163073
http://dx.doi.org/10.1186/s12959-022-00411-0

Ejemplares similares